OptimizeRx Corporation
OPRX
$6.60
$0.172.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 544.42% | -49.15% | 169.67% | -2,719.23% | 99.15% |
| Total Depreciation and Amortization | 32.07% | 0.00% | -0.20% | -24.42% | 32.30% |
| Total Amortization of Deferred Charges | -68.11% | -50.20% | 92.45% | 381.82% | -79.93% |
| Total Other Non-Cash Items | 19.02% | 31.45% | -4.49% | -48.31% | -70.13% |
| Change in Net Operating Assets | -111.04% | -2,726.67% | -99.07% | 178.57% | -807.49% |
| Cash from Operations | 121.36% | -29.80% | 18.04% | 1,851.52% | -88.94% |
| Capital Expenditure | -10.00% | 0.00% | 62.96% | -58.82% | 5.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | 40.35% | 44.66% | -39.19% |
| Cash from Investing | 2,160.00% | 77.27% | 47.62% | 30.00% | -30.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -400.00% | 88.89% | -800.00% | 80.00% | -400.00% |
| Issuance of Common Stock | -95.86% | -- | -- | -- | -- |
| Repurchase of Common Stock | -902.08% | -1,820.00% | 94.25% | 73.15% | -912.50% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,236.43% | 94.27% | -667.46% | 79.21% | -430.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.08% | 24,350.00% | -99.62% | 216.28% | -335.30% |